Evidence map›Paper›PMID 34495279›Full record

SynthesisRevista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo2021

The role of probiotics in the immune response and intestinal microbiota of children with celiac disease: a systematic review.

Camila Fernanda Jedwab, Bruna Cardoso de Mattos Boccalini Roston, Ana Beatriz Ferreira de Souza Toge, Isadora Fagundes Echeverria, Guilherme Ojea Gomes Tavares, Matheus Alves Alvares, Vera Esteves Vagnozzi Rullo, Marcella Rocha Machado de Oliveira

Registry-linked trialOpen access · diamondAbstract readSystematic Review
In one paragraph

Synthesis in Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03176095 (Celiac Disease Prevention With Probiotics), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03176095 nacompletednot on this map

Celiac Disease Prevention With Probiotics

TypeinterventionalSponsorLund UniversityRan2012 to 2015Enrolled90ConditionsCeliac Disease in ChildrenArmsProbiotic, Placebo
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Camila Fernanda JedwabCentro Universitário Lusíada, Santos, SP, Brazil.ORCID http://orcid.org/0000-0002-3285-4428
Bruna Cardoso de Mattos Boccalini RostonCentro Universitário Lusíada, Santos, SP, Brazil.ORCID http://orcid.org/0000-0002-9674-2548
Ana Beatriz Ferreira de Souza TogeCentro Universitário Lusíada, Santos, SP, Brazil.ORCID http://orcid.org/0000-0002-6872-0296
Isadora Fagundes EcheverriaCentro Universitário Lusíada, Santos, SP, Brazil.ORCID http://orcid.org/0000-0003-3118-3703
Guilherme Ojea Gomes TavaresCentro Universitário Lusíada, Santos, SP, Brazil.ORCID http://orcid.org/0000-0001-9632-8032
Matheus Alves AlvaresCentro Universitário Lusíada, Santos, SP, Brazil.ORCID http://orcid.org/0000-0001-6836-6023
Vera Esteves Vagnozzi RulloCentro Universitário Lusíada, Santos, SP, Brazil.ORCID http://orcid.org/0000-0002-4754-6612
Marcella Rocha Machado de OliveiraUniversidade Federal de São Paulo, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0001-8872-7789
Centro Universitário Lusíada · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate changes in peripheral immunological response (decrease in blood proinflammatory cytokines) and fecal microbiota (especially Bacteroidetes and Firmicutes) after administration of probiotics in children with celiac disease on a gluten-free diet. DATA SOURCE: The databases MEDLINE, LILACS, Springer and SciELO were used for this review, with the descriptors "celiac disease AND probiotics". At the end of the search, 168 articles were retrieved, four of which were included in the final qualitative synthesis, having as inclusion criteria randomized clinical trials and pediatric population (1-19 years) and, as exclusion criteria, interventions other than probiotics, studies with patients with other diseases associated with celiac disease, or patients who did not meet the diagnostic criteria. All elected studies were published until September 2020, without language restriction, with patients receiving strains of Bifidobacterium breve or B. longum and on a gluten-free diet. DATA SYNTHESIS: The studies show that the administration of probiotics along with a gluten-free diet, can approximate the fecal microbiota of celiac patients to typical conditions of healthy individuals, by restoring the abundance of some microbial communities that characterize the typical physiological condition. In addition, the administration of probiotics can reduce serum proinflammatory cytokines (mainly TNF-alpha).

conclusionsDespite the positive correlation between probiotics and fecal microbiota/serological markers in pediatric patients with celiac disease, we emphasize the need for future multicentric studies that should include a larger number of patients and a longer follow up period.

Indexed as

Celiac DiseaseGastrointestinal MicrobiomeProbioticsChildDiet, Gluten-FreeHumansImmunity

Identifiers

PMID34495279
PMCPMC8432160
OpenAlexW3197871948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.